Study of Molecular Characterisation of Early Operable Primary Breast Cancer in Pakistani Population
Recruiting
Observational Study
Breast Cancer
Molecular Pathway Deregulation
Treatment
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Sex
- Female
- Study type
- Observational
- Participants needed
- 300 (estimated)
- Sponsor
- Liaquat University of Medical & Health Sciences · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This study is looking at the biological characteristics of early operable primary breast cancer in Pakistani Population by using IHC
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Women with confirmed diagnosis of breast cancer without history of taking neoadjuvant therapy Good quality tumour samples available for IHC
Exclusion Criteria:
* patients received pre-operative chemotherapy or radiotherapy
Contacts